GHRP-2 Peptide
Showing all 9 results
Showing all 9 results
GHRP-2 is chosen for what it does not do
Its reputation rests on a comparison. GHRP-2 produces a growth hormone release at least as strong as GHRP-6 with substantially less appetite stimulation, which makes it the sensible pick when hunger is unwelcome. This section holds 9 lines from £35 to £84, averaging near £45 — the cheapest peptide section stocked.
Why the appetite difference exists
Both act on the same ghrelin receptor, so the difference is one of degree rather than mechanism. GHRP-2 is more selective toward growth hormone release relative to the appetite signalling, which is why the hunger is noticeable but not overwhelming.
Noticeable is the honest word. It is reduced compared with GHRP-6, not absent, and anyone told it has no appetite effect at all has been oversold.
What the selectivity costs
GHRP-2 raises cortisol and prolactin more than some alternatives in the class, particularly as the dose climbs. Elevated prolactin can produce its own set of problems, and it is a different pathway from the oestrogenic effects that aromatase inhibitors address — misreading one for the other is a common error.
This is the practical argument against pushing the dose up: past a point, additional growth hormone release comes with a disproportionate rise in the hormones you did not want.
Where it fits
| Situation | Better choice |
|---|---|
| Struggling to eat enough | GHRP-6 — the hunger is the point |
| Dieting | GHRP-2 — less appetite stimulation |
| Want oral, once daily | MK-677 |
As with the rest of the peptides range, it is commonly paired with a GHRH analogue because the two pathways combine for a larger release than either produces alone.
Practical notes
Supplied lyophilised, reconstituted with bacteriostatic water, refrigerated once mixed. Not suppressive, so no PCT is required. It is not a licensed medicine in the UK and is prohibited in sport.
Why the class is combined rather than escalated
Because GHRP and GHRH analogues act through separate pathways, adding a GHRH analogue produces more release than raising the GHRP dose does — and without the disproportionate cortisol and prolactin rise that dose escalation brings. This is the single most useful practical point about the class, and it points toward combining rather than increasing.
What to expect, realistically
Reported effects are gradual: sleep quality first, recovery over weeks, body composition over months if at all. Nothing in this class produces the visible, rapid change that somatropin can, and the several-fold price difference between them is the honest indicator of that gap.
Handling and verification
Lyophilised on arrival, reconstituted with bacteriostatic water, refrigerated after mixing and used within a few weeks. A vial of peptide powder cannot be judged by appearance, so the checks in how to check a brand is genuine matter more than usual.
Frequently asked questions
Is GHRP-2 stronger than GHRP-6?
At least as strong for growth hormone release, with less appetite stimulation.
Does it cause hunger at all?
Yes, but noticeably less. Claims that it has no appetite effect overstate the difference.
What is the trade-off?
Greater cortisol and prolactin elevation, especially at higher doses.
Is raised prolactin the same as high oestrogen?
No. Different pathway, different management — aromatase inhibitors do not address prolactin.
Why is this section the cheapest peptide category?
It is a short synthetic sequence and inexpensive to produce. Price here reflects the cost of synthesis rather than anything about the quality of what is in the vial.
